Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders (Q73060400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Ahmad Beydoun

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

S18-S22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

Clinical trial of carbazepine (tegretol) in trigeminal neuralgia

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Carbamazepine in the treatment of neuralgia. Use of side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

A four year double-blind study of tegretol in facial pain

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Trigeminal neuralgia: its treatment with two new carbamazepine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Neuropathic pain and injured nerve: Peripheral mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Neuropathic pain: aetiology, symptoms, mechanisms, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Mechanisms of pain in peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Use of carbamazepine in acute psychosis: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Carbamazepine vs lithium in the treatment and prophylaxis of mania

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

Lithium-carbamazepine neurotoxicity and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900017-3

7 January 2021

10.1016/S1525-5050(02)00017-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609349%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference